Back
WisdomTree Emerging Mkts Qual Div Gr ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
40
DGRE
WisdomTree Emerging Mkts Qual Div Gr ETF
Last Price:
27.31
Seasonality Move:
-0.74%
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
54.42
Seasonality Move:
11.04%
Sell
40
WisdomTree Emerging Mkts Qual Div Gr ETF (DGRE)
is a Sell
Is WisdomTree Emerging Mkts Qual Div Gr ETF a Buy, Sell or Hold?
- The current WisdomTree Emerging Mkts Qual Div Gr ETF [DGRE] share price is $27.28. The Score for DGRE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- DGRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DGRE Stock Price Chart
What is WisdomTree Emerging Mkts Qual Div Gr ETF's stock price today?
-
The WisdomTree Emerging Mkts Qual Div Gr ETF share price today is $27.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGRE is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
DGRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 53.28 | Buy |
Chaikin Money Flow: | -6659 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.89 - 27.51) | Buy |
Bollinger Bands (100): | (25.75 - 27.09) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.46 | Buy |
Relative Strength Index (14 RSI): | 67.83 | Buy |
Chaikin Money Flow: | -159819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.64 - 50.28) | Buy |
Bollinger Bands (100): | (39.46 - 48.56) | Buy |
DGRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.15 | Buy |
20-day SMA: | 27.24 | Buy |
50-day SMA: | 26.85 | Buy |
200-day SMA: | 25.59 | Buy |
8-day EMA: | 27.24 | Buy |
20-day EMA: | 27.14 | Buy |
50-day EMA: | 26.86 | Buy |
200-day EMA: | 25.64 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.55 | Buy |
20-day SMA: | 48.38 | Buy |
50-day SMA: | 47.86 | Buy |
200-day SMA: | 43.39 | Buy |
8-day EMA: | 50.8 | Buy |
20-day EMA: | 49.06 | Buy |
50-day EMA: | 47.17 | Buy |
200-day EMA: | 41.51 | Buy |
WisdomTree Emerging Mkts Qual Div Gr ETF Earnings Growth & DGRE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
WisdomTree Emerging Mkts Qual Div Gr ETF Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |